Fitchburg, WI, United States of America

Said A Goueli

This inventor holds 26 USPTO granted patents and 6 published patent applications and 9 EPO patents, primarily in Bioluminescence Detection. Top assignee: Promega Corporation. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Said A Goueli. Retrieved from https://idiyas.com/inventor/said-a-goueli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26 

% Patents Active = 84.6

 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 203(Granted Patents)


Location History:

  • Madison, WI (US) (2003 - 2010)
  • Ficthburg, WI (US) (2018)
  • Fitchburg, WI (US) (2000 - 2022)

Company Filing History:


Years Active: 2000-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Bioluminescence
Cyclic Nucleotide
Transferase Assay
Kinase Activity
ADP Detection
Nucleic Acid Reagents
Bioluminescent Assays
Phosphatase Assay
Protein Kinase
Detection Methods
Enzymatic Activity
Succinate Detection
26 patents (USPTO):Explore Patents

Sure, here is the article about inventor Said A Goueli:

Title: Spotlight on Inventor Said A Goueli from Fitchburg, WI

Introduction: Inventor Said A Goueli, based in Fitchburg, WI, is a prolific innovator with an impressive portfolio of 22 patents to his name. His groundbreaking work has spanned various fields, leaving a lasting impact on the world of science and technology.

Latest Patents: Among his latest patents is "Activation of bioluminescence by structural complementation," a revolutionary method that involves assembling a bioluminescent complex from non-luminescent peptide and/or polypeptide units. Additionally, Goueli has introduced "Systems and methods for determining cyclic nucleotide concentration and related pathway activation," offering advanced tools for detecting cyclic nucleotide concentrations in samples.

Career Highlights: Said A Goueli is associated with Promega Corporation, a prominent player in the biotechnology industry. His contributions have significantly enhanced the company's innovative capabilities, pushing the boundaries of scientific research and discovery.

Collaborations: Throughout his career, Goueli has collaborated with esteemed colleagues such as Hicham Zegzouti and Andrew S Dixon. Together, they have worked on various projects that have led to groundbreaking inventions and advancements in the field of biotechnology.

Conclusion: In conclusion, Said A Goueli stands out as a pioneering inventor whose relentless pursuit of innovation has led to the development of cutting-edge technologies. His creative solutions and collaborative spirit continue to inspire the scientific community, shaping the future of biotechnology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…